Supplements are found all across the United States – in grocery stores, supermarkets, health food vendors, supplement shops. Yet most of them are not backed by the rigorous research of clinical trials. This can’t be said for Elysium Health‘s Basis, a supplement crafted from nicotinamide riboside and pterostilbene, a combination that has been proven to boost the mean concentrations of nicotinamide adenine dinucleotide in its regular users.
How can consumers be certain of the above claim?
Virtually everyone familiar with supplements understands that they are not evaluated by the United States Food and Drug Administration, the same organization that carries out clinical trials on brand-new medications and recently-developed formulations of existing medications.
While Basis is not approved by the US FDA – much like any supplement on today’s market – its efficacy has been proven by a clinical trial funded by its manufacturer.
We’ll delve into the details of this clinical trial more deeply in following paragraphs.
What do the components of Basis do?
The function of pterostilbene and nicotinamide riboside is quite simple: nicotinamide riboside is converted into NAD+ – that’s nicotinamide adenine dinucleotide – in the body after it’s ingested. As long as NAD+ is present in sufficient quantities, pterostilbene can distribute proteins called sirtuins throughout cells that make up the human body.
Basis has four other components, and are as follows: hypromellose, silica, vegetable magnesium stearate, and microcrystalline cellulose. All of the above ingredients are either used in the capsule that holds together Basis’ two central components, or to extend the life of the supplement when stored.
The central idea behind the need for Basis is that the natural stores of NAD+ fade away in the human body as we get older. Children and young adults are full of NAD+, although such concentrations steadily drop over time, demoting cellular health, circadian rhythms, and other bodily functions. Rather than surrendering to our bodies’ natural aging process, the regular, once-daily consumption of Basis is alleged to improve stores of NAD+, in turn promoting cellular health.
What did the clinical trial mentioned earlier indicate?
120 people participated in the clinical trial. As all proper clinical trials are supposed to be, it was performed as a double-blinded, randomized, and controlled by placebo.
Healthy people between the ages of 60 and 80 were given either:
- A placebo
- 250 mg of nicotinamide riboside and 50 mg of pterostilbene
- 500 mg of nicotinamide riboside and 100 mg of pterostilbene
After four weeks, blood concentrations of NAD+ in the second group rose an average of 40 percent. Those in the third group rose a whopping 90 percent. As such, Elysium Health recommends healthy adults to take two capsules – equivalent to the third dosage seen above – per day.